Statement on the withdrawal of South African case

We have been made aware that the case before the South African High Court seeking to overcome the barriers cystic fibrosis patients face in accessing lifesaving modulator treatment resulting from Vertex’s monopoly has been withdrawn. Many in South Africa - and around the world - will have questions about the implications of this development for themselves and their loved ones. We are consulting with the CF community in SA and other allies to understand more about the implications of this decision, and we will share more information on our planned next steps as soon as possible. In the interim, we wish to make clear that our fight for universal access will only end when all patients have sustainable, affordable access to CF treatment, and everyone has realised their right to breathe.